Spots Global Cancer Trial Database for t acute lymphoblastic leukemia

Every month we try and update this database with for t acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	NCT03504644	B Acute Lymphob... Lymphoblasts 5 ... Recurrent Adult... Recurrent Child... Refractory Acut... T Acute Lymphob...	Laboratory Biom... Venetoclax Vincristine Lip...	18 Years -	Eastern Cooperative Oncology Group
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)	NCT06210750	T Acute Lymphob... T Lymphoblastic...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Dexamethasone Doxorubicin Echocardiograph... Lumbar Puncture Mercaptopurine Methotrexate Multigated Acqu... Navitoclax Nelarabine Pegaspargase Positron Emissi... Thioguanine Venetoclax Vincristine X-Ray Imaging	18 Years - 60 Years	National Cancer Institute (NCI)
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	NCT00408005	T Acute Lymphob... T Lymphoblastic...	Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	NCT00408005	T Acute Lymphob... T Lymphoblastic...	Asparaginase Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Laboratory Biom... Leucovorin Calc... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 30 Years	National Cancer Institute (NCI)
Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia	NCT02484430	B Acute Lymphob... B Acute Lymphob... B Acute Lymphob... Recurrent Adult... Refractory Adul... T Acute Lymphob...	Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	NCT03504644	B Acute Lymphob... Lymphoblasts 5 ... Recurrent Adult... Recurrent Child... Refractory Acut... T Acute Lymphob...	Laboratory Biom... Venetoclax Vincristine Lip...	18 Years -	Eastern Cooperative Oncology Group
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT00501826	T Acute Lymphob... T Lymphoblastic...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Venetoclax Vincristine Sul...	-	M.D. Anderson Cancer Center
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	NCT05602194	B Acute Lymphob... B Acute Lymphob... B Acute Lymphob... Lymphoblastic L... Mixed Phenotype... T Acute Lymphob...	Biospecimen Col... Calaspargase Pe... Levocarnitine Pegaspargase Quality-of-Life...	15 Years - 40 Years	Children's Oncology Group
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	NCT04128501	Acute Bilineal ... Acute Biphenoty... Acute Myeloid L... Mixed Phenotype... T Acute Lymphob... Therapy-Related...	Azacitidine Venetoclax	18 Years - 75 Years	M.D. Anderson Cancer Center
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	NCT03007147	Acute Lymphobla... B Acute Lymphob... Mixed Phenotype... T Acute Lymphob...	Allogeneic Hema... Calaspargase Pe... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Dexrazoxane Hyd... Doxorubicin Etoposide Filgrastim Ifosfamide Imatinib Mesyla... Laboratory Biom... Leucovorin Calc... Mercaptopurine Mercaptopurine Methotrexate Methylprednisol... Pegaspargase Prednisolone Questionnaire A... Therapeutic Hyd... Thioguanine Vincristine Sul...	1 Year - 21 Years	Children's Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: